Image pharmaphorum Editor News Drug firms fight US government's Iraq corruption probe US Department of Justice investigating J&J, Pfizer, Roche and others News Pain Therapeutics' opioid drug fails to gain FDA approval The US regulator has rejected Pain Therapeutics' abuse-deterrent opioid painkiller drug, Remoxy, for the fourth time. Market Access FDA grants leukaemia drug ‘breakthrough’ status A leukaemia drug has been granted ‘breakthrough therapy’ status by the US drug regulator. News New tuberculosis drug could help eradicate global killer A groundbreaking drug, rifampin, could help to end the global tuberculosis epidemic, according to researchers. Load more results
News Drug firms fight US government's Iraq corruption probe US Department of Justice investigating J&J, Pfizer, Roche and others
News Pain Therapeutics' opioid drug fails to gain FDA approval The US regulator has rejected Pain Therapeutics' abuse-deterrent opioid painkiller drug, Remoxy, for the fourth time.
Market Access FDA grants leukaemia drug ‘breakthrough’ status A leukaemia drug has been granted ‘breakthrough therapy’ status by the US drug regulator.
News New tuberculosis drug could help eradicate global killer A groundbreaking drug, rifampin, could help to end the global tuberculosis epidemic, according to researchers.
News EU clears first drug therapy for rare disease cALD Neuraxpharm and Minoryx' Nezglyal has become the first approved drug therapy in the EU for rare neurodegenerative disease cALD.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
